Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery, Mirna Collaborate on miRNA Mimics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mirna Therapeutics will test the effect of its proprietary miRNA mimics on a panel of Horizon Discovery's human isogenic cancer cell models, under a collaboration announced today.

Under the deal, Horizon's X-Man human discovery cell lines will be used to test the effects of common mutations in cancer patients on the efficacy of Mirna's miRNA mimics.

The project is being funded partly by a Cancer Prevention and Research Institute of Texas commercialization grant. Other terms of the deal were not disclosed.

In a statement, Paul Lammers, president and CEO of Mirna, said the partnership will "increase the understanding of how our highly potent tumor suppressor miRNA mimics act under human cancer cells characterized by different disease-causing mutations," which in turn will help the company to better define the best patient population for clinical trials.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.